BHC:NYSE
Bausch Health Companies Inc
$8.35
arrow_upward
+1.15%(+0.095) 1D
$8.33
arrow_downward
-0.24% (-0.020)bedtimeAfter hours
Closed: Nov 13, 4:00:03 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BHC...
Open
$8.25
High
$8.40
Low
$8.18
Mkt. cap
3.13B
Avg. vol.
3.86M
Volume
2.34M
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.30
Shares outstanding
374.27M
No. of employees
20K
Open
$8.25
High
$8.40
Low
$8.18
Mkt. cap
3.13B
Avg. vol.
3.86M
Volume
2.34M
52-wk high
$9.04
52-wk low
$4.33
EPS
-$2.29
Beta
0.30
Shares outstanding
374.27M
No. of employees
20K
News stories
From web sources and news partners
24/7 Wall St.
·
49 minutes ago
Gilead Beat the S&P 500 by More Than 25 Points in the Past Year, but $1,000 From a Decade Ago Is Still Worth Less Than $3,500
BigGo Finance
·
3 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
2 hours ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
Traders Union
·
30 minutes ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Bausch Health Companies Inc. is a pharmaceutical company headquartered in Laval, Quebec, Canada, with office in Bridgewater, New Jersey. It develops, manufactures and markets a range of pharmaceutical products in gastroenterology, hepatology, neuroscience, dermatology, dentistry, medical aesthetics, and international pharmaceuticals.
Bausch Health manufactures and markets branded pharmaceuticals, generic pharmaceuticals, and over-the-counter products directly or indirectly in more than 90 countries and regions, including the United States, Canada, Europe, the Middle East, Africa, Asia Pacific and Latin America. Wikipedia
About Bausch Health Companies Inc
CEOThomas J. Appio
Employees20.3K
Founded1960
HeadquartersLaval, Quebec, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitebauschhealth.com